文献速递糖尿病肥胖与代谢综合征

近期与早期妊娠期糖尿病子代婴儿体格生长轨迹比较

Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus.
PubMed 文献 · Diabetologia · 2019-08-09

前瞻性观察性出生队列比较近期(2011–2013年出生)与早期(2001–2009年出生)妊娠期糖尿病母亲子代(OGDM)及正常对照婴儿的生长轨迹。近期OGDM出生体重正常但皮褶厚度SDS较低,生后早期体重增长快、3–12月增长减缓,24月龄体脂仍低于对照。结论提示OGDM表型已由巨大儿转为出生体重正常化伴体脂减少。

要点

  • 近期OGDM出生体重SDS与对照相似,但皮褶厚度SDS更低。
  • 近期OGDM生后3月内体重增长快,3–12月增长减缓。
  • 24月龄时近期OGDM体脂仍低于对照婴儿。

核心结论

  • 近期OGDM与早期OGDM生长轨迹不同:出生体重正常化且出生时体脂减少,生后早期体重快速增长但后续体脂降低。
  • 避免巨大儿可能有益,但生长轨迹改变的长期健康影响尚不确定。

研究设计与样本

  • 前瞻性观察性出生队列,早期OGDM 98例(2001–2009年出生),近期OGDM 122例(2011–2013年出生),对照为876例无糖尿病史母亲正常出生体重婴儿。
  • 所有婴儿按同一方案在出生、3、12和24月龄测量体重、身长和皮褶厚度,GDM采用国际糖尿病与妊娠研究组标准定义。

主要发现

  • 早期OGDM出生体重SDS高于对照婴儿。
  • 近期OGDM出生体重和身长SDS与对照相似(均值±SD分别为0.1±1.0和-0.1±0.9),但皮褶厚度SDS更低(-0.4±0.6 vs 0.0±0.9;p<0.001)。
  • 生后早期OGDM3–12月龄体重和身长增长减少;近期OGDM3月龄内体重和皮褶厚度增长增加,3–12月龄增长减少。
  • 24月龄时近期OGDM皮褶厚度SDS低于对照(-0.3±0.7 vs 0.0±0.8;p<0.001)。
  • 所有时间点近期OGDM的生长测量值均低于早期OGDM。

临床怎么用

  • 对GDM母亲子代应关注出生时及生后不同阶段的生长轨迹,而非仅关注巨大儿。
  • 近期OGDM出生体重正常但体脂较低,生后早期体重增长较快,需动态监测后续体脂变化。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to explore the infancy growth trajectories of 'recent' and 'earlier' offspring of mothers with gestational diabetes mellitus (OGDM), each compared with the same control infants, and investigate whether 'recent' OGDM still exhibit a classical phenotype, with macrosomia and increased adiposity. METHODS: Within a prospective observational birth cohort, 98 'earlier' OGDM born between 2001 and 2009 were identified using 75 g oral glucose tolerance testing at 28 weeks gestation, 122 recent OGDM born between 2011 and 2013 were recruited postnatally through antenatal diabetes clinics, and 876 normal birthweight infants of mothers with no history of diabetes were recruited across the full study period as the control group. All infants followed the same study protocol (measurements at birth, 3, 12 and 24 months, including weight, length and skinfold thickness indicating adiposity, and detailed demographic data). In all cases, GDM was defined using the International Association of Diabetes and Pregnancy Study Group criteria. RESULTS: Earlier OGDM had higher birthweight SD scores (SDS) than control infants. Conversely, recent OGDM had similar birthweight- and length SDS to control infants (mean ± SD, 0.1 ± 1.0 and- 0.1 ± 0.9, respectively), but lower mean skinfold thickness SDS (-0.4 ± 0.6 vs 0.0 ± 0.9; p < 0.001). After birth, earlier OGDM showed reduced gains in weight and length between 3 and 12 months. In contrast, recent OGDM had increased weight and skinfold thickness gains until 3 months, followed by reduced gains in those variables from 3 to 12 months, compared with control infants. At 24 months, recent OGDM had lower adiposity than control infants (mean skinfold thickness SDS -0.3 ± 0.7 vs 0.0 ± 0.8; p < 0.001). At all time points recent OGDM had lower growth measurements than earlier OGDM. CONCLUSIONS/INTERPRETATION: Recent OGDM showed different growth trajectories to the earlier group, namely normalisation of birthweight and reduced adiposity at birth, followed by initial rapid weight gain but subsequent reduced adiposity postnatally. While avoidance of macrosomia at birth may be advantageous, the longer-term health implications of these changing growth trajectories are uncertain.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Prentice PM, Olga L, Petry CJ, et al. Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus. Diabetologia. 2019. PMID: 31396660. doi:10.1007/s00125-019-4970-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。